MGMT and glioblastoma: Indeed, EANO evidence-based guidelines on diagnosis and treatment of diffuse gliomas of adulthood report that TMZ might only be effective in GBM patients with methylated MGMT gene promoter, whereas its effectiveness on patients with unmethylated MGMT gene promoter is modest (8, 30).